Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma
Gemcitabine and cisplatin serve as appropriate treatments for patients with cholangiocarcinoma (CCA). Our previous study using histoculture drug response assay (HDRA), demonstrated individual response patterns to gemcitabine and cisplatin. The current study aimed to identify predictive biomarkers fo...
Saved in:
Main Authors: | Manida Suksawat (Author), Jutarop Phetcharaburanin (Author), Poramate Klanrit (Author), Nisana Namwat (Author), Narong Khuntikeo (Author), Attapon Titapun (Author), Apiwat Jarearnrat (Author), Vanlakhone Vilayhong (Author), Prakasit Sa-ngiamwibool (Author), Anchalee Techasen (Author), Arporn Wangwiwatsin (Author), Panupong Mahalapbutr (Author), Jia V. Li (Author), Watcharin Loilome (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma
by: Yingpinyapat Kittirat, et al.
Published: (2022) -
Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression
by: Jittima Tomacha, et al.
Published: (2021) -
Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction
by: Yingpinyapat Kittirat, et al.
Published: (2021) -
In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines
by: Dokduang H, et al.
Published: (2020) -
Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand.
by: Chanika Worasith, et al.
Published: (2019)